Crick
HomeTrialsGenesDrugs23andMeGraphBlogContact
  • Home
  • Trials
  • Genes
  • Drugs
  • 23andMe
  • Graph
  • Blog
  • Contact
Crick

An open-source clinical intelligence platform. Explore clinical trials, gene networks, and molecular structures using public data sources.

Data Sources

  • ClinicalTrials.gov
  • OpenTargets
  • ClinVar
  • PubChem

Links

  • Contact
  • About
  • Privacy

© 2026 Crick. All rights reserved.

Crick is for educational purposes only. Not medical advice.

Results for “Coronavirus Covid-19 Infection Variant Omicron”

34 trials

Showing 20 of 34 results

Testing effectiveness (Phase 2)UnknownNCT05522829
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine SCTV01E-1 in Population Aged Above 18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Early research (Phase 1)Study completedNCT05923424
What this trial is testing

A Trial to Learn if Different Doses of REGN17092 Are Safe in Healthy Adults

Who this might be right for
Healthy Volunteers
Regeneron Pharmaceuticals 40
Testing effectiveness (Phase 2)UnknownNCT05345873
What this trial is testing

Evaluate the Immunogenicity and Safety of a Recombinant Protein COVID-19 Vaccine as a Booster Dose in Population Aged 12-17 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 300
Early research (Phase 1)UnknownNCT05434585
What this trial is testing

Evaluate Safety, Tolerability, and Immunogenicity of SARS-CoV-2 Variant (COVID-19) mRNA Vaccines

Who this might be right for
COVID-19
Suzhou Abogen Biosciences Co., Ltd. 60
Testing effectiveness (Phase 2)WithdrawnNCT04290871
What this trial is testing

Nitric Oxide Gas Inhalation for Severe Acute Respiratory Syndrome in COVID-19.

Who this might be right for
Coronavirus Covid-19 Infection Variant OmicronSARS (Severe Acute Respiratory Syndrome)
Xijing Hospital
Early research (Phase 1)Study completedNCT05972993
What this trial is testing

A Safety and Immune Response Study to Evaluate Varying Doses of an mRNA Vaccine Against Coronavirus Disease 2019 (COVID-19) in Healthy Adults

Who this might be right for
COVID-19
GlaxoSmithKline 114
Not applicableStudy completedNCT06170307
What this trial is testing

Left Atrial Function of COVID-19-recovered Patients During the Surge of Omicron Variants

Who this might be right for
COVID-19 Pandemic
Haiyan Wang 150
Large-scale testing (Phase 3)UnknownNCT05749926
What this trial is testing

Immunogenicity and Reactogenicity of the Beta-variant Recombinant Protein Booster Vaccine (VidPrevtyn Beta, Sanofi) Compared to a Bivalent mRNA Vaccine (Comirnaty Original/Omicron BA.4-5, BioNTech-Pfizer) in Adults Previously Vaccinated With at Least 3 Doses of COVID-19 mRNA Vaccine

Who this might be right for
Vaccine ReactionCOVID-19
Assistance Publique - Hôpitaux de Paris 248
Large-scale testing (Phase 3)Study completedNCT05249829
What this trial is testing

Evaluate the Immunogenicity and Safety of Omicron Variant Vaccines in Comparison With mRNA-1273 Booster Vaccine for COVID-19

Who this might be right for
SARS-CoV-2
ModernaTX, Inc. 3,548
Large-scale testing (Phase 3)UnknownNCT05323461
What this trial is testing

Evaluate the Immunogenicity and Safety of Two Recombinant Protein COVID-19 Vaccines in Population Aged ≥18 Years as Booster Vaccines

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 1,800
Testing effectiveness (Phase 2)Study completedNCT05593042
What this trial is testing

Immunogenicity Evaluation of Omicron Variant-based Vaccine and a Trivalent Vaccine in Adults Against COVID-19 in Chile

Who this might be right for
COVID-19Vaccines
Pontificia Universidad Catolica de Chile 551
Not applicableUnknownNCT05234294
What this trial is testing

Long Covid After COVID-19 Infection With Omicron Variant

Who this might be right for
COVID-19
Faroese Hospital System 15,000
Not applicableUnknownNCT05379543
What this trial is testing

Echocardiographic Manifestation in Patients With Omicron Variant of COVID-19

Who this might be right for
COVID-19
RenJi Hospital 200
Testing effectiveness (Phase 2)Study completedNCT05652543
What this trial is testing

A PhaseⅡ Study to Evaluate the Safety & Immunogenicity of SARS-CoV-2 Alpha/Beta/Delta/Omicron Variants COVID-19 Vaccine

Who this might be right for
COVID-19 Pandemic
Sinocelltech Ltd. 518
Not applicableStudy completedNCT05813600
What this trial is testing

Efficacy and Safety of Nirmatrelvir/Ritonavir for Treating Omicron Variant of COVID-19

Who this might be right for
Omicron Variant of COVID-19
Xiangao Jiang 58
Testing effectiveness (Phase 2)WithdrawnNCT05308602
What this trial is testing

Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E (Two Recombinant Protein COVID-19 Vaccines) in Population Aged ≥12 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd.
Large-scale testing (Phase 3)Study completedNCT05973006
What this trial is testing

Phase 3 Adolescent Study for SARS-CoV-2 rS Variant Vaccines

Who this might be right for
COVID-19
Novavax 400
Testing effectiveness (Phase 2)UnknownNCT05239806
What this trial is testing

A Phase II Clinical Trial to Evaluate the Immunogenicity and Safety of SCTV01C and SCTV01E in Population Aged ≥12 Years Previously Fully Vaccinated With Inactivated COVID-19 Vaccine

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 400
Large-scale testing (Phase 3)UnknownNCT05308576
What this trial is testing

Evaluate the Efficacy and Safety of SCTV01E (a COVID-19 Vaccine) in Population Aged ≥18 Years

Who this might be right for
COVID-19SARS-CoV-2 Infection
Sinocelltech Ltd. 10,000
Post-approval studies (Phase 4)Study completedNCT06208540
What this trial is testing

Clinical Characteristics and Treatment of Anosmia and Ageusia Due to SARS-CoV2 Variants

Who this might be right for
Post-covid-19 Persistent Smell and Taste Disorders
Sherifa Ahmed Hamed 160
Load More Results

Filters

Phase
Early Phase 1
Phase 1
Phase 2
Phase 3
Phase 4
Status
Recruiting
Active, Not Recruiting
Not Yet Recruiting
Completed
Enrolling by Invitation